OMNICOM GROUP INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Omnicom Group Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Omnicom Group Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.04B, a 0.22% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.04B +$2.3M +0.22% Sep 30, 2024 10-Q 2024-10-16
Q2 2024 $1.02B -$57.4M -5.35% Jun 30, 2024 10-Q 2024-07-17
Q1 2024 $1.02B -$56.1M -5.21% Mar 31, 2024 10-Q 2024-04-17
Q4 2023 $1.05B -$119M -10.2% Dec 31, 2023 10-Q 2024-10-16
Q3 2023 $1.04B -$112M -9.72% Sep 30, 2023 10-Q 2023-10-18
Q2 2023 $1.07B -$110M -9.31% Jun 30, 2023 10-Q 2023-07-19
Q1 2023 $1.08B -$127M -10.6% Mar 31, 2023 10-Q 2023-04-19
Q4 2022 $1.17B -$37.9M -3.15% Dec 31, 2022 10-K 2024-02-07
Q3 2022 $1.15B +$53.7M +4.88% Sep 30, 2022 10-Q 2022-10-19
Q2 2022 $1.18B +$40.7M +3.56% Jun 30, 2022 10-Q 2022-07-20
Q1 2022 $1.2B +$27.8M +2.36% Mar 31, 2022 10-Q 2022-04-20
Q4 2021 $1.2B -$20.5M -1.68% Dec 31, 2021 10-K 2023-02-08
Q3 2021 $1.1B -$153M -12.2% Sep 30, 2021 10-Q 2021-10-20
Q2 2021 $1.14B -$127M -9.99% Jun 30, 2021 10-Q 2021-07-20
Q1 2021 $1.18B -$179M -13.2% Mar 31, 2021 10-Q 2021-04-20
Q4 2020 $1.22B -$175M -12.5% Dec 31, 2020 10-K 2022-02-09
Q3 2020 $1.25B -$130M -9.38% Sep 30, 2020 10-Q 2020-10-27
Q2 2020 $1.27B -$166M -11.6% Jun 30, 2020 10-Q 2020-07-28
Q1 2020 $1.36B +$56.3M +4.34% Mar 31, 2020 10-Q 2020-04-28
Q4 2019 $1.4B +$1.4B Dec 31, 2019 10-K 2021-02-18
Q3 2019 $1.38B Sep 30, 2019 10-Q 2019-10-15
Q2 2019 $1.44B Jun 30, 2019 10-Q 2019-07-17
Q1 2019 $1.3B Mar 31, 2019 10-Q 2019-04-16
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.